tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Technical Analysis

183 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Immunome is a Sell.
Immunome’s (IMNM) 20-Day exponential moving average is 13.23, while Immunome’s (IMNM) share price is $13.71, making it a Buy.
Immunome’s (IMNM) 50-Day exponential moving average is 14.21, while Immunome’s (IMNM) share price is $13.71, making it a Sell.

Immunome (IMNM) Pivot Points

Jul 19, 2024, 05:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.46
13.75
14.21
14.50
14.96
15.25
15.71
Fibonacci
13.75
14.04
14.22
14.50
14.79
14.97
15.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Jul 19, 2024, 05:14 PM
Period
Simple
Exponential
MA5
13.86Buy
13.81Buy
MA10
13.02Buy
13.35Buy
MA20
12.60Buy
13.23Buy
MA50
13.97Buy
14.21Sell
MA100
17.53Sell
15.12Sell
MA200
14.55Sell
13.23Buy
Immunome’s (IMNM) 10-Day exponential moving average is 13.35, while Immunome’s (IMNM) share price is $13.71, making it a Buy.
Immunome’s (IMNM) 100-Day exponential moving average is 15.12, while Immunome’s (IMNM) share price is $13.71, making it a Sell.
Immunome’s (IMNM) stock price is $13.71 and Immunome’s (IMNM) 50-day simple moving average is 13.97, creating a Buy signal.
Immunome’s (IMNM) stock price is $13.71 and Immunome’s (IMNM) 100-day simple moving average is 17.53, creating a Sell signal.
Immunome’s (IMNM) stock price is $13.71 and Immunome’s (IMNM) 200-day simple moving average is 14.55, creating a Sell signal.

Immunome (IMNM) Technical Indicators

Jul 19, 2024, 05:14 PM
Name
Value
Implied Action
RSI (14)
55.05
Neutral
STOCH (9,6)
88.35
Sell
STOCHRSI (14)
89.42
Sell
MACD (12,26)
-0.09
Sell
ADX (14)
21.51
Neutral
Williams %R
-25.45
Buy
CCI (14)
163.49
Sell
ATR (14)
0.83
-
Ultimate Oscillator
57.65
Neutral
ROC
16.29
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 55.05, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 21.51, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is 163.49, creating a Sell signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 16.29, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Buy.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 55.05, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is -0.09, which suggests IMNM is a Sell.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 13.86, which suggests IMNM is a Buy.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 12.60, which suggests IMNM is a Buy.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 13.97, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 14.55, which suggests IMNM is a Sell.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -25.45, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is 163.49, which suggests IMNM is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis